section name header

Pronunciation

ra-NOLE-a-zeen audio

Indications

REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Highly variable.

Distribution: Unknown.

Metabolism/Excretion: Metabolized in the gut (P-glycoprotein) and by the liver (primarily CYP3A and less by CYP2D6); <5% excreted unchanged in urine and feces.

Half-life: 7 hr.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: TORSADES DE POINTES, palpitations, QTc prolongation.

EENT: tinnitus.

GI: abdominal pain, constipation, dry mouth, nausea, vomiting.

GU: acute renal failure.

Neuro: dizziness, headache.

Interactions

Drug-Drug:

Drug-Natural Products:

Drug-Food:

Route/Dosage

Implementation

US Brand Names

Ranexa

Classifications

Therapeutic Classification: antianginals

Availability

(Generic available)

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
POunknown2–5 hr12 hr

Assessment

Lab Test Considerations:

Pot. Nursing Diagnoses

Patient/Family Teaching

Evaluation/Desired Outcomes

Code

NDC Code*